RÉSUMÉ
The postpartum period is commonly accompanied by emotional changes, which for many new mothers includes a reduction in anxiety. Previous research in rodents has shown that the postpartum attenuation in anxiety is dependent on offspring contact and has further implicated enhanced GABAergic neurotransmission as an underlying mechanism. However, the specific brain regions where GABA acts to regulate the offspring-induced reduction in postpartum anxiety requires further investigation. Here, we test the hypothesis that offspring interactions suppress anxiety-like behavior in postpartum female rats via GABA signaling in the medial prefrontal cortex (mPFC). Our results show a postpartum reduction in anxiety-like behavior, an effect which was abolished by localized infusion of the GABAA receptor antagonist bicuculline in the mPFC. We also show that activation of GABAA receptors in the mPFC by the agonist muscimol was effective in restoring anxiolyisis in mothers separated from their pups. Lastly, we show that heightened anxiety-like behavior in pup-separated mothers was accompanied by a lower number and percentage of activated GABAergic neurons within the mPFC. Together, these results suggest that mother-offspring interactions reduce anxiety-like behavior in postpartum females via GABAA neurotransmission in the mPFC and in doing so provide insight into mechanisms that may become dysfunctional in mothers who experience high postpartum anxiety.
Sujet(s)
Anxiété/métabolisme , Agonistes du récepteur GABA-A/pharmacologie , Antagonistes du récepteur GABA-A/pharmacologie , Neurones GABAergiques/physiologie , Séparation d'avec la mère , Cortex préfrontal/physiologie , Troubles du postpartum/métabolisme , Acide gamma-amino-butyrique/physiologie , Animaux , Anxiété/traitement médicamenteux , Comportement animal/effets des médicaments et des substances chimiques , Comportement animal/physiologie , Bicuculline/pharmacologie , Modèles animaux de maladie humaine , Femelle , Agonistes du récepteur GABA-A/administration et posologie , Antagonistes du récepteur GABA-A/administration et posologie , Humains , Mâle , Muscimol/pharmacologie , Cortex préfrontal/métabolisme , Troubles du postpartum/traitement médicamenteux , Rat Sprague-DawleyRÉSUMÉ
Healthcare organizations have invested significant resources into integrating comprehensive electronic health record (EHR) systems into clinical care. EHRs digitize healthcare in ways that allow for repurposing of clinical information to support quality improvement, research, population health, and health system analytics. This has facilitated the development of Learning Health Systems. Learning health systems (LHS) merge healthcare delivery with research, data science, and quality improvement processes. The LHS cycle begins and ends with the clinician-patient interaction, and aspires to provide continuous improvements in quality, outcomes, and health care efficiency. Although, the health sector has been slow to embrace the LHS concept, innovative approaches for improving healthcare, such as a LHS, have shown that better outcomes can be achieved by engaging patients and physicians in communities committed to a common purpose. Here, we explore the mission of a pediatric LHS, such as PEDSnet, which is driven by the distinctive goals of a child's well-being. Its vision is to create a national LHS architecture in which all pediatric institutions can participate. While challenges still exist in the development and adoption of LHS, these challenges are being met with innovative strategies and strong collaborative relationships to reduce system uncertainty while improving patient outcomes.
Sujet(s)
Recherche biomédicale , Science des données , Prestations des soins de santé/méthodes , Dossiers médicaux électroniques , Médecine factuelle/méthodes , Pédiatrie/méthodes , Amélioration de la qualité , Mégadonnées , Enfant , Prestations des soins de santé/organisation et administration , Médecine factuelle/organisation et administration , Humains , Pédiatrie/organisation et administration , Relations médecin-patient , États-UnisRÉSUMÉ
Numerous studies in animals and humans have established that oxytocin (OT) reduces anxiety. In rats, the prelimbic (PL) subregion of the medial prefrontal cortex (mPFC) is among the brain areas implicated in the anxiolytic actions of OT. However, questions remain about the anatomical and receptor specificity of OT and its mechanism of action. Here we assessed whether the regulation of anxiety by mPFC OT is restricted to the PL subregion and evaluated whether oxytocin receptor (OTR) activation is required for OT to have an anxiolytic effect. We also examined whether OT interacts with GABA in the mPFC to reduce anxiety and investigated the extent to which OT in the mPFC affects activation of mPFC GABA neurons as well as neuronal activation in the amygdala, a primary target of the mPFC which is part of the neural network regulating anxiety. We found that OT reduced anxiety-like behavior when delivered to the PL, but not infralimbic or anterior cingulate subregions of the mPFC. The anxiolytic effect of OT in the PL mPFC was blocked by pretreatment with an OTR, but not a vasopressin receptor, antagonist as well as with a GABAA receptor antagonist. Lastly, administration of OT to the PL mPFC was accompanied by increased activation of GABA neurons in the PL mPFC and altered neuronal activation of the amygdala following anxiety testing. These results demonstrate that OT in the PL mPFC attenuates anxiety-related behavior and may do so by engaging GABAergic neurons which ultimately modulate downstream brain regions implicated in anxiety.
Sujet(s)
Anxiété/métabolisme , Ocytocine/métabolisme , Cortex préfrontal/cytologie , Cortex préfrontal/métabolisme , Récepteurs à l'ocytocine/métabolisme , Animaux , Antagonistes des récepteurs de l'hormone antidiurétique/pharmacologie , Anxiété/traitement médicamenteux , Antagonistes du récepteur GABA-A/pharmacologie , Neurones GABAergiques/cytologie , Neurones GABAergiques/effets des médicaments et des substances chimiques , Neurones GABAergiques/métabolisme , Gyrus du cingulum/cytologie , Gyrus du cingulum/effets des médicaments et des substances chimiques , Gyrus du cingulum/métabolisme , Mâle , Activité motrice/effets des médicaments et des substances chimiques , Activité motrice/physiologie , Ocytocine/administration et posologie , Cortex préfrontal/effets des médicaments et des substances chimiques , Rat Sprague-Dawley , Récepteurs GABA-A/métabolisme , Récepteurs à l'ocytocine/agonistes , Récepteurs à l'ocytocine/antagonistes et inhibiteurs , Récepteurs à la vasopressine/métabolisme , Transmission synaptique/effets des médicaments et des substances chimiques , Transmission synaptique/physiologieRÉSUMÉ
Pregnancy and the postpartum period are times of profound behavioral change including alterations in cognitive function. This has been most often studied using hippocampal-dependent tasks assessing spatial learning and memory. However, less is known about the cognitive effects of motherhood for tasks that rely on areas other than the hippocampus. We have previously shown that postpartum females perform better on the extradimensional phase of an attentional set shifting task, a measure of cognitive flexibility which is dependent on the medial prefrontal cortex (mPFC). The present experiments aimed to extend this work by examining the importance of postpartum stage as well as offspring and parity in driving improved mPFC cognitive function during motherhood. We also examined whether the neuropeptide oxytocin, which plays a role in regulating numerous maternal functions, mediates enhanced cognitive flexibility during motherhood. Our results demonstrate that compared to virgin females, cognitive flexibility is enhanced in mothers regardless of postpartum stage and is not affected by parity since both first (primiparous) and second (biparous) time mothers showed the enhancement. Moreover, we found that improved cognitive flexibility in mothers requires the presence of offspring, as removal of the pups abolished the cognitive enhancement in postpartum females. Lastly, using an oxytocin receptor antagonist, we demonstrate that oxytocin signaling in the mPFC is necessary for the beneficial effects of motherhood on cognitive flexibility. Together, these data provide insights into the temporal, experiential and hormonal factors which regulate mPFC-dependent cognitive function during the postpartum period.
Sujet(s)
Comportement maternel/physiologie , Ocytocine/physiologie , Parité/physiologie , Période du postpartum/physiologie , Animaux , Attention/physiologie , Cognition/physiologie , Femelle , Hippocampe/physiologie , Mâle , Mémoire/physiologie , Cortex préfrontal/physiologie , Grossesse , Rats , Rat Sprague-DawleyRÉSUMÉ
The maternal brain is remarkably plastic and exhibits multifaceted neural modifications. Neurogenesis has emerged as one of the mechanisms by which the maternal brain exhibits plasticity. This review highlights what is currently known about peripartum-associated changes in adult neurogenesis and the underlying hormonal mechanisms. We also consider the functional consequences of neurogenesis in the peripartum brain and extent to which this process may play a role in maternal care, cognitive function and postpartum mood. Finally, while most work investigating the effects of parenting on adult neurogenesis has focused on mothers, a few studies have examined fathers and these results are also discussed.
Sujet(s)
Encéphale/physiologie , Comportement maternel/physiologie , Neurogenèse/physiologie , Plasticité neuronale/physiologie , Période du postpartum/physiologie , Grossesse/physiologie , Animaux , Encéphale/métabolisme , Femelle , Période du postpartum/métabolisme , Grossesse/métabolismeRÉSUMÉ
The neuropeptide oxytocin (OT) acts on a widespread network of brain regions to regulate numerous behavioral adaptations during the postpartum period including maternal care, maternal aggression, and anxiety. In the present study, we examined whether this network also includes the medial prefrontal cortex (mPFC). We found that bilateral infusion of a highly specific oxytocin receptor antagonist (OTR-A) into the prelimbic (PL) region of the mPFC increased anxiety-like behavior in postpartum, but not virgin, females. In addition, OTR blockade in the postpartum mPFC impaired maternal care behaviors and enhanced maternal aggression. Overall, these results suggest that OT in the mPFC modulates maternal care and aggression, as well as anxiety-like behavior, during the postpartum period. Although the relationship among these behaviors is complicated and further investigation is required to refine our understanding of OT actions in the maternal mPFC, these data nonetheless provide new insights into neural circuitry of OT-mediated postpartum behaviors.
RÉSUMÉ
The neuropeptide oxytocin (OT) is anxiolytic in rodents and humans. However, the specific brain regions where OT acts to regulate anxiety requires further investigation. The medial prefrontal cortex (mPFC) has been shown to play a role in the modulation of anxiety-related behavior. In addition, the mPFC contains OT-sensitive neurons, expresses OT receptors, and receives long range axonal projections from OT-producing neurons in the hypothalamus, suggesting that the mPFC may be a target where OT acts to diminish anxiety. To investigate this possibility, female rats were administered OT bilaterally into the prelimbic (PL) region of the mPFC and anxiety-like behavior assessed. In addition, to determine if the effects of OT on anxiety-like behavior are sex dependent and to evaluate the specificity of OT, male and female anxiety-like behavior was tested following delivery of either OT or the closely related neuropeptide arginine vasopressin (AVP) into the PL mPFC. Finally, the importance of endogenous OT in the regulation of anxiety-like behavior was examined in male and female rats that received PL infusions of an OT receptor antagonist (OTR-A). Overall, even though males and females showed some differences in their baseline levels of anxiety-like behavior, OT in the PL region of the mPFC decreased anxiety regardless of sex. In contrast, neither AVP nor an OTR-A affected anxiety-like behavior in males or females. Together, these findings suggest that although endogenous OT in the PL region of the mPFC does not influence anxiety, the PL mPFC is a site where exogenous OT may act to attenuate anxiety-related behavior independent of sex.